Search
for
Sort by
Research 211–240 of 411
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Testicular Steroidogenesis
- Phytochemistry and pharmacological studies of Plumbago zeylanica L.: a medicinal plant review
- Screening the Chemical Composition and Bioactivity of <i>Cerasus serrulata</i> Flower Extracts Using Two Extraction Methods
- Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health
- Wound Healing Effect of Supercritical Carbon Dioxide Datura metel L. Leaves Extracts: An In Vitro Study of Anti-Inflammation, Cell Migration, MMP-2 Inhibition, and the Modulation of the Sonic Hedgehog Pathway in Human Fibroblasts
- DHT and E2 synthesis-related proteins and receptors expression in male yak skin during different hair follicle stages
- Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors
- Exosome-based Therapies for Androgenetic Alopecia: Mechanisms, MicroRNAs, and Clinical Prospects
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Longitudinal clinical course in patients with 5α-reductase type 2 deficiency treated with testosterone and dihydrotestosterone during infancy and puberty
- Mechanisms of Puerariae Lobatae Radix in regulating sebaceous gland secretion: insights from network pharmacology and experimental validation
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Synergistic Trichogenic Efficacy of Wedelia chinensis and Cassytha filiformis Emulgel in Murine Models
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- 5α-Reductase type 1 inhibition of Oryza sativa bran extract prepared by supercritical carbon dioxide fluid
- Post-finasteride syndrome – does it really exist?
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Post-finasteride syndrome: An emerging clinical problem
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Towards a consensus on how to diagnose and quantify female pattern hair loss – The ‘Female Pattern Hair Loss Severity Index (FPHL-SI)’
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol